Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results

Go back to Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results
(NASDAQ: FULC) Delayed: 3.76 -0.01 (0.27%)
Previous Close $3.77    52 Week High
Open $3.77    52 Week Low
Day High $3.81    P/E N/A 
Day Low $3.76    EPS
Volume 3,656,214